Get startedLog in
    Picture of Kiniksa Pharmaceuticals International logo

    KNSA — Kiniksa Pharmaceuticals International News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    All News

    Brief: Kiniksa Pharmaceuticals Announces Closing Of Global License Agreement With Genentech For Vixarelimab

    Picture of Kiniksa Pharmaceuticals International logoKiniksa Pharmaceuticals International
    12/09/2022 13:41
    Sept 12 (Reuters) - Kiniksa Pharmaceuticals Ltd  KNSA.O :
    * KINIKSA PHARMACEUTICALS ANNOUNCES CLOSING OF GLOBAL
LICENSE
AGREEMENT WITH GENENTECH FOR VIXARELIMAB

Source text for Eikon:  ID:nGNX6fd7XG 
Further company coverage:  KNSA.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Kiniksa Pharmaceuticals International

    See all news